Bringing a new product to market is always a complex journey. From ideation to launch, startups and established companies alike face challenges in validating ideas, managing resources, and ensuring ...

One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

The invention, rapid manufacturing and distribution of the COVID-19 vaccine demonstrates exactly how fast the life sciences treatment development pipeline can move when the right factors are in play.